Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas
NCT02223208· Phase 1/2· Fondazione Italiana Linfomi - ETS· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error